• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UHMK1通过与MTHFD2形成正反馈回路促进前列腺癌进展。

UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.

作者信息

Zhang Chi, Huang Xi, Hu Cheng, Tang Bowen, Wu Jianjie, Sun Zhuolun, Zhu Weian, Zhou Xiangfu, Xiao Hengjun, Wang Hua

机构信息

Department of Urology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, China.

Department of Ultrasound, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, 510120, China.

出版信息

Oncol Res. 2025 Aug 28;33(9):2331-2351. doi: 10.32604/or.2025.065119. eCollection 2025.

DOI:10.32604/or.2025.065119
PMID:40918462
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12408860/
Abstract

BACKGROUND

U2AF homology motif kinase 1 (UHMK1) has been associated with RNA processing and protein phosphorylation, thereby influencing tumor progression. The study aimed to explore its regulatory mechanisms and biological functions in human prostate cancer (PCa).

METHODS

In this study, we systematically evaluated the expression and prognostic significance of UHMK1 in public databases, followed by validation through immunohistochemistry (IHC) in PCa specimens. Both gain-of-function and loss-of-function experiments were conducted to elucidate the role of UHMK1 and . Additionally, a series of molecular and biochemical assays were performed to investigate the regulatory mechanisms underlying UHMK1 activity.

RESULTS

Our findings revealed that UHMK1 expression was significantly upregulated in PCa tissues and correlated with poor patient prognosis, as demonstrated by analysis of public datasets and confirmed by immunohistochemical staining. Functional studies showed that UHMK1 depletion suppressed tumor cell proliferation and metastasis, while its overexpression promoted these processes. Mechanistically, we identified that UHMK1 phosphorylates nuclear receptor coactivator 3 (NCOA3), which subsequently activates activating transcription factor 4 (ATF4) to upregulate methylenetetrahydrofolate dehydrogenase 2 (MTHFD2) transcription. Interestingly, MTHFD2 was found to reciprocally enhance UHMK1 expression, establishing a positive feedback loop.

CONCLUSIONS

In conclusion, our data suggest that the UHMK1-MTHFD2 axis forms a positive feedback loop that drives PCa progression. Targeting this loop represents a promising therapeutic strategy for restraining prostate cancer development and progression.

摘要

背景

U2AF同源基序激酶1(UHMK1)与RNA加工和蛋白质磷酸化相关,从而影响肿瘤进展。本研究旨在探讨其在人类前列腺癌(PCa)中的调控机制和生物学功能。

方法

在本研究中,我们系统评估了公共数据库中UHMK1的表达及其预后意义,随后通过免疫组织化学(IHC)在PCa标本中进行验证。进行了功能获得和功能丧失实验以阐明UHMK1的作用。此外,还进行了一系列分子和生化分析以研究UHMK1活性的调控机制。

结果

我们的研究结果显示,通过对公共数据集的分析以及免疫组织化学染色证实,PCa组织中UHMK1表达显著上调,且与患者预后不良相关。功能研究表明,敲低UHMK1可抑制肿瘤细胞增殖和转移,而过表达则促进这些过程。机制上,我们发现UHMK1使核受体共激活因子3(NCOA3)磷酸化,随后激活激活转录因子4(ATF4)以上调亚甲基四氢叶酸脱氢酶2(MTHFD2)的转录。有趣的是,发现MTHFD2可相互增强UHMK1的表达,从而建立一个正反馈环。

结论

总之,我们的数据表明UHMK1-MTHFD2轴形成一个驱动PCa进展的正反馈环。靶向该环代表了一种抑制前列腺癌发生和进展的有前景的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/24ee21bd00c7/OncolRes-33-65119-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/9956e6df313a/OncolRes-33-65119-f001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/7e04258d747c/OncolRes-33-65119-f002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/4a6666fba87c/OncolRes-33-65119-f003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/90144c403c52/OncolRes-33-65119-f004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/344491fb8ac0/OncolRes-33-65119-f005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/24ee21bd00c7/OncolRes-33-65119-f006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/9956e6df313a/OncolRes-33-65119-f001a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/7e04258d747c/OncolRes-33-65119-f002a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/4a6666fba87c/OncolRes-33-65119-f003a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/90144c403c52/OncolRes-33-65119-f004a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/344491fb8ac0/OncolRes-33-65119-f005a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ac67/12408860/24ee21bd00c7/OncolRes-33-65119-f006.jpg

相似文献

1
UHMK1 Promotes Prostate Cancer Progression through a Positive Feedback Loop with MTHFD2.UHMK1通过与MTHFD2形成正反馈回路促进前列腺癌进展。
Oncol Res. 2025 Aug 28;33(9):2331-2351. doi: 10.32604/or.2025.065119. eCollection 2025.
2
SREBF1-mediated SND1 transcriptional activation promotes prostate cancer progression via MTDH interaction through the SESN2/AMPK/mTOR axis.SREBF1介导的SND1转录激活通过SESN2/AMPK/mTOR轴与MTDH相互作用促进前列腺癌进展。
J Transl Med. 2025 Aug 7;23(1):885. doi: 10.1186/s12967-025-06762-2.
3
SHCBP1 promotes tumor cell proliferation, migration, and invasion, and is associated with poor prostate cancer prognosis.SHCBP1 促进肿瘤细胞增殖、迁移和侵袭,并与前列腺癌不良预后相关。
J Cancer Res Clin Oncol. 2020 Aug;146(8):1953-1969. doi: 10.1007/s00432-020-03247-1. Epub 2020 May 23.
4
Integrin αVβ1-activated PYK2 promotes the progression of non-small-cell lung cancer via the STAT3-VGF axis.整合素 αVβ1 激活的 PYK2 通过 STAT3-VGF 轴促进非小细胞肺癌的进展。
Cell Commun Signal. 2024 Jun 6;22(1):313. doi: 10.1186/s12964-024-01639-1.
5
CircUBE3A(2,3,4,5) promotes adenylate-uridylate-rich binding factor 1 nuclear translocation to suppress prostate cancer metastasis.环状结构蛋白 3A(2,3,4,5)促进富含腺苷酸-尿苷酸结合因子 1 的核转位以抑制前列腺癌转移。
Cancer Lett. 2024 Apr 28;588:216743. doi: 10.1016/j.canlet.2024.216743. Epub 2024 Feb 27.
6
Prognostic and immunological implications of cathepsin Z overexpression in prostate cancer.组织蛋白酶Z在前列腺癌中过表达的预后及免疫学意义
Front Immunol. 2025 Jun 11;16:1618487. doi: 10.3389/fimmu.2025.1618487. eCollection 2025.
7
Exportin XPO7 acts as an oncogenic factor in prostate cancer via upregulation of TCF3.XPO7 外排蛋白在前列腺癌中充当致癌因子,通过上调 TCF3 实现。
J Cancer Res Clin Oncol. 2023 Aug;149(10):7663-7677. doi: 10.1007/s00432-023-04705-2. Epub 2023 Mar 31.
8
Ring-finger protein RNF126 promotes prostate cancer progression via regulation of MBNL1.环状结构域蛋白RNF126通过调控MBNL1促进前列腺癌进展。
Sci Rep. 2025 Jul 4;15(1):23847. doi: 10.1038/s41598-025-04629-6.
9
Reciprocal regulation between RACGAP1 and AR contributes to endocrine therapy resistance in prostate cancer.RACGAP1 和 AR 之间的相互调节导致前列腺癌内分泌治疗耐药。
Cell Commun Signal. 2024 Jun 19;22(1):339. doi: 10.1186/s12964-024-01703-w.
10
[Expression of SIPA1 in colorectal cancer and its impact on its biological behavior].[信号通路抑制因子1在结直肠癌中的表达及其对其生物学行为的影响]
Zhonghua Zhong Liu Za Zhi. 2025 Jul 23;47(7):657-668. doi: 10.3760/cma.j.cn112152-20240812-00338.

本文引用的文献

1
Cancer statistics, 2025.2025年癌症统计数据。
CA Cancer J Clin. 2025 Jan-Feb;75(1):10-45. doi: 10.3322/caac.21871. Epub 2025 Jan 16.
2
MTHFD2 Enhances cMYC O-GlcNAcylation to Promote Sunitinib Resistance in Renal Cell Carcinoma.MTHFD2增强cMYC的O-连接N-乙酰葡糖胺化以促进肾细胞癌对舒尼替尼的耐药性。
Cancer Res. 2025 Mar 14;85(6):1113-1129. doi: 10.1158/0008-5472.CAN-24-0050.
3
Expression and clinical significance of U2AF homology motif kinase 1 in oral squamous cell carcinoma.U2AF 同源结构域激酶 1 在口腔鳞状细胞癌中的表达及临床意义。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2024 Nov;138(5):626-634. doi: 10.1016/j.oooo.2024.07.005. Epub 2024 Jul 22.
4
[Stage at diagnosis of prostate cancer in an institutional hospital. Review and comparison of national and international data].[某机构医院前列腺癌的诊断分期。国内外数据的回顾与比较]
Rev Med Chil. 2023 Jun;151(6):711-716. doi: 10.4067/s0034-98872023000600711.
5
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer-2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent.EAU-EANM-ESTRO-ESUR-ISUP-SIOG 前列腺癌指南-2024 更新。第一部分:筛查、诊断和以治愈为目的的局部治疗。
Eur Urol. 2024 Aug;86(2):148-163. doi: 10.1016/j.eururo.2024.03.027. Epub 2024 Apr 13.
6
MYC induces CDK4/6 inhibitors resistance by promoting pRB1 degradation.MYC 通过促进 pRB1 降解诱导 CDK4/6 抑制剂耐药性。
Nat Commun. 2024 Feb 29;15(1):1871. doi: 10.1038/s41467-024-45796-w.
7
GTF2H4 regulates partial EndMT via NF-κB activation through NCOA3 phosphorylation in ischemic diseases.在缺血性疾病中,GTF2H4通过NCOA3磷酸化激活NF-κB来调控部分内皮-间充质转化。
Innovation (Camb). 2024 Jan 8;5(2):100565. doi: 10.1016/j.xinn.2024.100565. eCollection 2024 Mar 4.
8
CRISPR genome-wide screening identifies PAK1 as a critical driver of ARSI cross-resistance in prostate cancer progression.CRISPR 全基因组筛选鉴定 PAK1 为前列腺癌进展中 ARSI 交叉耐药的关键驱动因素。
Cancer Lett. 2024 Apr 10;587:216725. doi: 10.1016/j.canlet.2024.216725. Epub 2024 Feb 15.
9
Serine/threonine kinase 36 induced epithelial-mesenchymal transition promotes docetaxel resistance in prostate cancer.丝氨酸/苏氨酸激酶 36 诱导上皮-间质转化促进前列腺癌多西他赛耐药。
Sci Rep. 2024 Jan 6;14(1):729. doi: 10.1038/s41598-024-51360-9.
10
Targeting MTHFD2 to Exploit Cancer-Specific Metabolism and the DNA Damage Response.靶向 MTHFD2 以利用癌症特异性代谢和 DNA 损伤反应。
Cancer Res. 2024 Jan 2;84(1):9-16. doi: 10.1158/0008-5472.CAN-23-1290.